SMR Conference

Prospective multicenter evaluation (MERLIN_001 trial) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 cN0 melanoma
Gallery
Prospective multicenter evaluation (MERLIN_001 trial) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 cN0 melanoma

Prospective multicenter evaluation (MERLIN_001 trial) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 cN0 melanoma

Sondak et al., SMR Conference.

kari.sharp@gmail.com2024-10-13T02:30:12-07:00October 13, 2024|

CP-GEP Identifies T1a Melanoma Patients At Risk of Sentinel Lymph Node Metastasis
Gallery
CP-GEP Identifies T1a Melanoma Patients At Risk of Sentinel Lymph Node Metastasis

CP-GEP Identifies T1a Melanoma Patients At Risk of Sentinel Lymph Node Metastasis

W. Yu et al. 2024. SMR Conference.

kari.sharp@gmail.com2024-10-10T05:50:45-07:00October 10, 2024|

Long-term follow-up of melanoma patient risk stratified by a clinicopathologic and gene expression profile (CP-GEP) model: a -center United States cohort study.
Gallery
Long-term follow-up of melanoma patient risk stratified by a clinicopathologic and gene expression profile (CP-GEP) model: a -center United States cohort study.

Long-term follow-up of melanoma patient risk stratified by a clinicopathologic and gene expression profile (CP-GEP) model: a -center United States cohort study.

W. Yu et al. 2024. SMR Conference.

kari.sharp@gmail.com2023-11-09T14:58:02-08:00November 9, 2023|